The University of Chicago Header Logo

Connection

Richard Whitley to Herpesvirus 3, Human

Back to Details
This is a "connection" page, showing publications Richard Whitley has written about Herpesvirus 3, Human.
Richard Whitley
Connection Strength
1.084
Herpesvirus 3, Human
  1. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes. 2007 Sep; 14 Suppl 2:25-9.
    View in: PubMed
    Score: 0.304
  2. Sorivudine: a potent inhibitor of varicella zoster virus replication. Adv Exp Med Biol. 1996; 394:41-4.
    View in: PubMed
    Score: 0.135
  3. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One. 2011; 6(7):e22527.
    View in: PubMed
    Score: 0.100
  4. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol. 2010 May; 48 Suppl 1:S20-8.
    View in: PubMed
    Score: 0.091
  5. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007 Mar 29; 356(13):1338-43.
    View in: PubMed
    Score: 0.074
  6. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
    View in: PubMed
    Score: 0.073
  7. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells. J Immunol. 1986 Jun 01; 136(11):4243-8.
    View in: PubMed
    Score: 0.070
  8. Replication of varicella zoster virus in Raji cells. Virus Res. 1986 Jun; 4(4):337-42.
    View in: PubMed
    Score: 0.070
  9. Herpes zoster: focus on treatment in older adults. Antiviral Res. 1999 Dec 31; 44(3):145-54.
    View in: PubMed
    Score: 0.045
  10. Antiviral resistance: mechanisms, clinical significance, and future implications. J Antimicrob Chemother. 1996 Mar; 37(3):403-21.
    View in: PubMed
    Score: 0.034
  11. Assays for antiviral drug resistance. Antiviral Res. 1995 Apr; 26(4):403-13.
    View in: PubMed
    Score: 0.032
  12. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus. Pediatr Infect Dis J. 1989 Sep; 8(9):584-5.
    View in: PubMed
    Score: 0.022
  13. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep; 89(3):375-88.
    View in: PubMed
    Score: 0.010
  14. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9.
    View in: PubMed
    Score: 0.009
  15. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr. 1992 Apr; 120(4 Pt 1):627-33.
    View in: PubMed
    Score: 0.007
  16. Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells. J Immunol. 1987 Feb 15; 138(4):1229-33.
    View in: PubMed
    Score: 0.005
  17. Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979 Dec; 139(12):1341-5.
    View in: PubMed
    Score: 0.003
  18. Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study. J Infect Dis. 1976 Jun; 133 Suppl:A184-91.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.